X-linked agammaglobulinemia--gene cloning and future prospects

Immunol Today. 1993 Nov;14(11):554-8. doi: 10.1016/0167-5699(93)90187-P.

Abstract

The btk gene has recently been identified as the causative gene in X-linked agammaglobulinemia (XLA). This has opened up many new possibilities for the treatment of this B-cell immunodeficiency. Christine Kinnon and colleagues review the high degree of sequence of homology of btk to the non-receptor tyrosine kinases and speculate on putative roles for this gene in B-cell development.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase
  • Agammaglobulinemia / genetics*
  • Animals
  • B-Lymphocytes / immunology
  • Cloning, Molecular*
  • Disease Models, Animal
  • Forecasting
  • Genetic Linkage*
  • Humans
  • Mice
  • Mice, Inbred CBA
  • Protein-Tyrosine Kinases / chemistry
  • Protein-Tyrosine Kinases / physiology
  • X Chromosome*

Substances

  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human